Patients with hepatitis C virus (HCV) genotype 3 infection remain a difficult-to-cure population. This study evaluated the efficacy and safety of sofosbuvir-based regimen in genotype 3 patients in a real-world...
from Most Recent Articles: Virology Journal http://bit.ly/2WImxH5
via IFTTT
No comments:
Post a Comment